Boston, MA USA

Our News on Newswise

BIDMC's George Tsokos, MD, Honored by Lupus Foundation and the American College of Rheumatology

George Tsokos, MD, Chief of Rheumatology at Beth Israel Deaconess Medical Center and a national leader in the field of lupus research was honored by both the Lupus Foundation and the American College of Rheumatology with two awards presented at the...
21-Nov-2014 12:00 PM EST

Charles Safran, MD Wins Morris F. Collen Award of Excellence in Medical Informatics

BOSTON – Charles Safran, MD, FACMI, Chief of the Division of Clinical Informatics at Beth Israel Deaconess Medical Center (BIDMC), has received the American College of Medical Informatics’ 2014 Morris F. Collen Award in recognition of his...
20-Nov-2014 4:00 PM EST

Antiangiogenic Treatment Improves Survival Rates in Animal Model of Ovarian Cancer

Treatment with 3TSR antiangiogenic agent is shown to regress tumors and improve effectiveness of chemotherapy in an animal model of ovarian cancer.
20-Nov-2014 12:00 PM EST

Researchers Show microRNA Silencing Is a Successful New Model for Cancer Therapeutics

By exploiting a unique feature of the tumor microenvironment, scientists identify a novel delivery platform that leads to the inhibition of microRNA activity -- and the control of cancer growth
17-Nov-2014 12:00 PM EST

Scientists Identify a Role for Carbon Monoxide in Battling Bacterial Infections

New findings support the possibility that, in the future, small, non-toxic doses of carbon monoxide could be used therapeutically to provide the immune system with an infection-fighting advantage.
11-Nov-2014 8:00 AM EST

BIDMC's Bruce Furie, MD, Honored as Distinguished Scientist by American Heart Association

Bruce Furie, MD, Chief of the Division of Hemostasis and Thrombosis at Beth Israel Deaconess Medical Center (BIDMC) has been named a 2014 Distinguished Scientist by the American Heart Association.
7-Nov-2014 11:00 AM EST

Osteoporosis, Not Just a Woman’s Disease

While osteoporosis prevention and treatment efforts have historically been focused on post-menopausal women, a new study from Beth Israel Deaconess Medical Center (BIDMC) suggests that critical opportunities are being lost by not focusing more...
4-Nov-2014 9:35 AM EST

Silencing the Speech Gene FOXP2 Causes Breast Cancer Cells to Metastasize

A research team led by investigators at Beth Israel Deaconess Medical Center has identified an unexpected link between a transcription factor known to regulate speech and language development and metastatic colonization of breast cancer.
22-Oct-2014 9:00 AM EDT

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos